Daniel Besser
Overview
Explore the profile of Daniel Besser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Besser D
Curr Protoc Stem Cell Biol
. 2020 Sep;
55(1):e129.
PMID: 32956522
Current Protocols in Stem Cell Biology is publishing a special collection of eight articles from members of the PluriCore Network in the German Stem Cell Network. © 2020 Wiley Periodicals...
2.
Mahler S, Besser D
Stem Cell Res
. 2019 Dec;
42():101672.
PMID: 31838379
The German Stem Cell Network (GSCN) aims at creating synergies between all areas of basic and applied stem cell research and to provide an interface between science, education, politics and...
3.
Wang J, Singh M, Sun C, Besser D, Prigione A, Ivics Z, et al.
Nat Protoc
. 2018 Oct;
14(8):2596.
PMID: 30374153
In the published version of this paper, the authors omitted a funding source. L.D.H. acknowledges support from the European Research Council (Advanced Grant ERC-2014-ADG 669207). The original article has not...
4.
Wang J, Singh M, Sun C, Besser D, Prigione A, Ivics Z, et al.
Nat Protoc
. 2016 Jan;
11(2):327-46.
PMID: 26797457
The ability to derive and stably maintain ground-state human pluripotent stem cells (hPSCs) that resemble the cells seen in vivo in the inner cell mass has the potential to be...
5.
Qi J, Yu Y, Akilli Ozturk O, Holland J, Besser D, Fritzmann J, et al.
Gut
. 2015 Jul;
65(10):1690-701.
PMID: 26156959
Objectives: We have previously identified a 115-gene signature that characterises the metastatic potential of human primary colon cancers. The signature included the canonical Wnt target gene BAMBI, which promoted experimental...
6.
Wang J, Xie G, Singh M, Ghanbarian A, Rasko T, Szvetnik A, et al.
Nature
. 2014 Oct;
516(7531):405-9.
PMID: 25317556
Naive embryonic stem cells hold great promise for research and therapeutics as they have broad and robust developmental potential. While such cells are readily derived from mouse blastocysts it has...
7.
8.
Bieback K, Wuchter P, Besser D, Franke W, Becker M, Ott M, et al.
J Mol Med (Berl)
. 2012 Jun;
90(7):773-82.
PMID: 22648521
Due to their multi-lineage differentiation capacity, support of haematopoiesis, immunomodulation and secretion of proregenerative factors, mesenchymal stem/stromal cells (MSCs) are in the focus of intense research since decades. The literature...
9.
Bieback K, Hecker A, Schlechter T, Hofmann I, Brousos N, Redmer T, et al.
Cytotherapy
. 2012 Feb;
14(5):570-83.
PMID: 22300364
Background Aims: Mesenchymal stromal cells (MSC) are promising candidates for innovative cell therapeutic applications. For clinical-scale manufacturing, different supplements have been evaluated as alternatives for the commonly used fetal bovine...
10.
Where do you come from; where do you go? Pluripotency, differentiation and malfunction of stem cells
Spagnoli F, Besser D, Benitah S
EMBO Rep
. 2011 Dec;
13(1):9-11.
PMID: 22157892
The international conference 'Stem Cells in Development and Disease' took place in September 2011 at the Max-Delbrück-Center for Molecular Medicine (MDC) in Berlin. It brought together scientists working on different...